Anemia Management In Chronic Kidney Disease - PowerPoint PPT Presentation

1 / 63
About This Presentation
Title:

Anemia Management In Chronic Kidney Disease

Description:

Associates in Nephrology ... Majority of CRI Patients are Anemic at First Nephrology Visit. Hematocrit at the First Nephrology Visit. Greater Boston Area Chart Audit ... – PowerPoint PPT presentation

Number of Views:296
Avg rating:3.0/5.0
Slides: 64
Provided by: nmhmfs
Category:

less

Transcript and Presenter's Notes

Title: Anemia Management In Chronic Kidney Disease


1
Anemia Management In Chronic Kidney Disease
  • Paul Crawford, M.D., F.A.C.P.
  • Associates in Nephrology
  • Chairman of the Minority Intervention Kidney
    Education (MIKE) Program of the American Kidney
    Fund
  • Medical Director of the Evergreen Park Fresinius
    Medical Care Dialysis Unit
  • Member of the National Anemia Action Council
    (NAAC)
  • April 27, 2005
  • National Minority Health Month Foundations 2005
    Annual National Health Disparities Summit

2
(No Transcript)
3
(No Transcript)
4
(No Transcript)
5
(No Transcript)
6
(No Transcript)
7
(No Transcript)
8
(No Transcript)
9
(No Transcript)
10
(No Transcript)
11
(No Transcript)
12
(No Transcript)
13
(No Transcript)
14
(No Transcript)
15
(No Transcript)
16
(No Transcript)
17
(No Transcript)
18
(No Transcript)
19
(No Transcript)
20
(No Transcript)
21
(No Transcript)
22
(No Transcript)
23
(No Transcript)
24
(No Transcript)
25
Anemia Begins Early in CKD
Serum Creatinine (mg/dl)
Kazmi, JASN, submitted Greater Boston Area Chart
Audit
26
Anemia is a Mortality Risk Multiplier
27
Majority of CRI Patients are Anemic at First
Nephrology Visit
Hematocrit at the First Nephrology Visit
Greater Boston Area Chart Audit
28
Strategies to Optimize Management of CKD Anemia
  • Identify patients with falling hematocrit
  • Measure serum iron, ferritin and transferrin
    sats.
  • Begin oral iron supplements
  • Start EPO subQ weekly
  • Increase Hct no faster than 2/month
  • Target Hct of 33-36
  • Measure serum iron, transferrin saturation after
    first month and every three months
  • thereafter
  • Close monitoring of BP and progression of CRF

29
(No Transcript)
30
(No Transcript)
31
(No Transcript)
32
(No Transcript)
33
(No Transcript)
34
(No Transcript)
35
(No Transcript)
36
(No Transcript)
37
(No Transcript)
38
(No Transcript)
39
(No Transcript)
40
(No Transcript)
41
(No Transcript)
42
(No Transcript)
43
(No Transcript)
44
(No Transcript)
45
(No Transcript)
46
(No Transcript)
47
(No Transcript)
48
(No Transcript)
49
(No Transcript)
50
(No Transcript)
51
(No Transcript)
52
(No Transcript)
53
(No Transcript)
54
(No Transcript)
55
(No Transcript)
56
(No Transcript)
57
(No Transcript)
58
(No Transcript)
59
(No Transcript)
60
(No Transcript)
61
(No Transcript)
62
(No Transcript)
63
(No Transcript)
64
(No Transcript)
65
(No Transcript)
66
(No Transcript)
67
(No Transcript)
68
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com